Lauren H. Augustyniak

FDA investigator

Appears on 5 documents from 2024 to 2026, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42(c)(10)(iii)).

5
Documents on file
5.8
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 29 observations

Activity by year

2024: 2, 2025: 1, 2026: 2

Where

New York 5

Is Lauren H. Augustyniak coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 The Mentholatum CompanyMar 23, 2026 · Orchard Park, New York
483 LENA Group Inc. DBA Lornamead ProductsJan 21, 2026 · Tonawanda, New York
483 Ames Goldsmith CorpMay 22, 2025 · Glens Falls, New York
483 Form 483 · FEI 3016774658Nov 8, 2024 · Clarence, New York
483 Pine Pharmaceuticals, LLCSep 30, 2024 · Tonawanda, New York

About this profile

What does Lauren H. Augustyniak inspect?

Lauren H. Augustyniak appears on 5 documents on file covering 5 sites, mostly in New York.

What do they cite most often?

21 CFR 211.42(c)(10)(iii) (design and construction features), followed by 21 CFR 211.100 and 21 CFR 211.160(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lauren H. Augustyniak is dated Mar 23, 2026.